Page last updated: 2024-10-22

amiodarone and Congestive Ophthalmopathy

amiodarone has been researched along with Congestive Ophthalmopathy in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"Thyroid disorders and eye diseases are interrelated through several mechanisms thus, awareness of this relation has a great impact on early diagnosis and treatment."5.05Thyroid and Eye: Where They Meet in Clinical Practice. ( El-Eshmawy, MM; Shahin, M, 2020)
"Thyrotoxicosis is a common disorder, especially in women."2.48Thyrotoxicosis. ( Boelaert, K; Franklyn, JA, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
El-Eshmawy, MM1
Shahin, M1
Franklyn, JA1
Boelaert, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257]240 participants (Actual)Interventional2017-04-25Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for amiodarone and Congestive Ophthalmopathy

ArticleYear
Thyroid and Eye: Where They Meet in Clinical Practice.
    Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:1

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Diabetic Retinopathy; Eye; Eye Dise

2020
Thyrotoxicosis.
    Lancet (London, England), 2012, Mar-24, Volume: 379, Issue:9821

    Topics: Agranulocytosis; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Autoimmune Diseases; Child; Ex

2012